vs
Side-by-side financial comparison of BioLineRx Ltd. (BLRX) and Heritage Distilling Holding Company, Inc. (IPST). Click either name above to swap in a different company.
BioLineRx Ltd. is the larger business by last-quarter revenue ($5.4M vs $4.7M, roughly 1.1× Heritage Distilling Holding Company, Inc.). BioLineRx Ltd. runs the higher net margin — 9.0% vs -6862.0%, a 6871.0% gap on every dollar of revenue.
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
Newport Craft Brewing & Distilling Company is a brewery and distillery located in Newport, Rhode Island. Established in 1999 as the Coastal Extreme Brewing Company, it was the first microbrewery in Newport and began distilling operations in 2006. The company produces a range of beers and spirits that are distributed in the Northeastern United States. In 2018 it adopted its current name to reflect its combined brewing and distilling operations. Newport Craft is owned by Audrain Hospitality Gro...
BLRX vs IPST — Head-to-Head
Income Statement — Q2 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $4.7M |
| Net Profit | $484.0K | $-323.7M |
| Gross Margin | 83.4% | 68.5% |
| Operating Margin | -107.0% | -2622.6% |
| Net Margin | 9.0% | -6862.0% |
| Revenue YoY | — | — |
| Net Profit YoY | 102.6% | — |
| EPS (diluted) | $0.00 | $-31.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $4.7M | ||
| Q3 25 | — | $3.0M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $1.1M | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | $5.4M | — | ||
| Q2 23 | $0 | — |
| Q4 25 | — | $-323.7M | ||
| Q3 25 | — | $196.3M | ||
| Q2 25 | — | $-7.3M | ||
| Q1 25 | — | $-3.0M | ||
| Q3 24 | — | $-3.4M | ||
| Q2 24 | $484.0K | — | ||
| Q2 23 | $-18.5M | — |
| Q4 25 | — | 68.5% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 24.9% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | 83.4% | — | ||
| Q2 23 | — | — |
| Q4 25 | — | -2622.6% | ||
| Q3 25 | — | -38.4% | ||
| Q2 25 | — | -503.0% | ||
| Q1 25 | — | -224.5% | ||
| Q3 24 | — | -118.1% | ||
| Q2 24 | -107.0% | — | ||
| Q2 23 | — | — |
| Q4 25 | — | -6862.0% | ||
| Q3 25 | — | 6566.2% | ||
| Q2 25 | — | -551.9% | ||
| Q1 25 | — | -277.8% | ||
| Q3 24 | — | -194.9% | ||
| Q2 24 | 9.0% | — | ||
| Q2 23 | — | — |
| Q4 25 | — | $-31.89 | ||
| Q3 25 | — | $16.97 | ||
| Q2 25 | — | $-0.77 | ||
| Q1 25 | — | $-0.34 | ||
| Q3 24 | — | $-160.41 | ||
| Q2 24 | $0.00 | — | ||
| Q2 23 | $-0.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.6M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $13.9M | $98.2M |
| Total Assets | $64.6M | $108.8M |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $9.6M | — | ||
| Q2 23 | $10.1M | — |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $13.0M | ||
| Q1 25 | — | $13.0M | ||
| Q3 24 | — | $15.0M | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q4 25 | — | $98.2M | ||
| Q3 25 | — | $420.4M | ||
| Q2 25 | — | $-2.9M | ||
| Q1 25 | — | $-329.0K | ||
| Q3 24 | — | $-34.0M | ||
| Q2 24 | $13.9M | — | ||
| Q2 23 | $21.1M | — |
| Q4 25 | — | $108.8M | ||
| Q3 25 | — | $482.8M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $27.1M | ||
| Q3 24 | — | $31.1M | ||
| Q2 24 | $64.6M | — | ||
| Q2 23 | $58.9M | — |
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $-7.5M |
| Free Cash FlowOCF − Capex | $-25.5M | — |
| FCF MarginFCF / Revenue | -472.8% | — |
| Capex IntensityCapex / Revenue | 1.1% | 0.0% |
| Cash ConversionOCF / Net Profit | -52.56× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-7.5M | ||
| Q3 25 | — | $-4.3M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | $-25.4M | — | ||
| Q2 23 | $-17.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-4.3M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | $-25.5M | — | ||
| Q2 23 | $-17.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -144.7% | ||
| Q2 25 | — | -115.3% | ||
| Q1 25 | — | -187.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | -472.8% | — | ||
| Q2 23 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.1% | — | ||
| Q2 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.02× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -52.56× | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLRX
Segment breakdown not available.
IPST
| Direct To Consumer | $3.0M | 63% |
| Wholesale | $1.2M | 26% |
| Other | $517.7K | 11% |
